Next Article in Journal
Development and Biological Properties of a New Live Attenuated Mumps Vaccine Strain
Previous Article in Journal
Trends in DTP3 Vaccination in Asia (2012–2023)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 13
Issue 8
10.3390/vaccines13080878
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Vaccines 2024, 12(12), 1317.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317

by
Matteo Riccò
1,
Bahaa Abu-Raya
2,3,4,
Giancarlo Icardi
5,6,
Vana Spoulou
7,
David Greenberg
8,
Oana Falup Pecurariu
9,10,
Ivan Fan-Ngai Hung
11,
Albert Osterhaus
12,
Vittorio Sambri
13,14 and
Susanna Esposito
15,*
1
Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL), AUSL-IRCCS di Reggio Emilia, Via Amendola 2, 42122 Reggio Emilia, Italy
2
Canadian Center for Vaccinology, Dalhousie University, IWK Health Centre and the Nova Scotia Health Authority, Halifax, NS B3K 6R8, Canada
3
Departments of Pediatrics, Dalhousie University, Halifax, NS B3K 6R8, Canada
4
Departments of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada
5
Department of Health Sciences (DISSAL), University of Genoa, 16132 Genoa, Italy
6
IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy
7
Immunobiology and Vaccinology Research Laboratory and Infectious Diseases Department “MAKKA”, First Department of Paediatrics, “Aghia Sophia” Children’s Hospital, Athens Medical School, 11527 Athens, Greece
8
Pediatric Infectious Diseases Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University, Beer Sheva 8410501, Israel
9
Children’s Clinical Hospital Brasov, 500063 Brasov, Romania
10
Faculty of Medicine Brasov, Transilvania University, 500019 Brasov, Romania
11
Division of Infectious Diseases, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR 999077, China
12
Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559 Hannover, Germany
13
Unit of Microbiology, The Greater Romagna Area Hub Laboratory, 47522 Cesena, Italy
14
Department Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy
15
Pediatric Clinic, Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy
 
add Show full affiliation list
 
remove Hide full affiliation list
*
Author to whom correspondence should be addressed.
Vaccines 2025, 13(8), 878; https://doi.org/10.3390/vaccines13080878
Submission received: 24 July 2025 / Accepted: 29 July 2025 / Published: 20 August 2025
Browse Figure
Versions Notes
The authors would like to make the following corrections to this published paper [1]. In the original publication, there was a mistake in Figure 4 as published. Factual inaccuracies in Figure 4 were corrected. In fact, actual data do not support difference in efficacy between the respective vaccines as the primary endpoints from the clinical trials have been defined differently, and therefore no comparison between vaccines is appropriate, also taking into account the heterogeneous follow up during RSV seasons. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Riccò, M.; Abu-Raya, B.; Icardi, G.; Spoulou, V.; Greenberg, D.; Pecurariu, O.F.; Hung, I.F.-N.; Osterhaus, A.; Sambri, V.; Esposito, S. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317. [Google Scholar] [CrossRef] [PubMed]
Vaccines 13 00878 g004
Figure 4. Summary of the decline in vaccine efficacy (reported with their corresponding 95% Confidence Intervals [95%CI]) in the prevention of lower respiratory tract illnesses (LRTI) with 3 or more findings during first and second respiratory syncytial virus (RSV) season [28,87,210,213,221,241,243,258]. Preliminary data on Season 3 of RSVpreF3 have been retrieved from ACIP Meeting of 24 October 2024 [259]. The figure is not intended for vaccine comparison and in particular, the x axis does not represent a defined timeline, but seasonal efficacy only.
Figure 4. Summary of the decline in vaccine efficacy (reported with their corresponding 95% Confidence Intervals [95%CI]) in the prevention of lower respiratory tract illnesses (LRTI) with 3 or more findings during first and second respiratory syncytial virus (RSV) season [28,87,210,213,221,241,243,258]. Preliminary data on Season 3 of RSVpreF3 have been retrieved from ACIP Meeting of 24 October 2024 [259]. The figure is not intended for vaccine comparison and in particular, the x axis does not represent a defined timeline, but seasonal efficacy only.
Vaccines 13 00878 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Riccò, M.; Abu-Raya, B.; Icardi, G.; Spoulou, V.; Greenberg, D.; Pecurariu, O.F.; Hung, I.F.-N.; Osterhaus, A.; Sambri, V.; Esposito, S. Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317. Vaccines 2025, 13, 878. https://doi.org/10.3390/vaccines13080878

AMA Style

Riccò M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Pecurariu OF, Hung IF-N, Osterhaus A, Sambri V, Esposito S. Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317. Vaccines. 2025; 13(8):878. https://doi.org/10.3390/vaccines13080878

Chicago/Turabian Style

Riccò, Matteo, Bahaa Abu-Raya, Giancarlo Icardi, Vana Spoulou, David Greenberg, Oana Falup Pecurariu, Ivan Fan-Ngai Hung, Albert Osterhaus, Vittorio Sambri, and Susanna Esposito. 2025. "Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317" Vaccines 13, no. 8: 878. https://doi.org/10.3390/vaccines13080878

APA Style

Riccò, M., Abu-Raya, B., Icardi, G., Spoulou, V., Greenberg, D., Pecurariu, O. F., Hung, I. F.-N., Osterhaus, A., Sambri, V., & Esposito, S. (2025). Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317. Vaccines, 13(8), 878. https://doi.org/10.3390/vaccines13080878

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop